| 1. |
Saira Naseem, Ahmed Temirak, Aqeel Imran, Saquib Jalil,Shamool Fatima, Parham Taslimi, Jamshed Iqbal, Mussarat Tasleem, Muhammad Nawaz Tahir f and Zahid Shafiq (2023), "Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease", RSC Advances , pp: 17526-17535, Vol: 13, Impact Factor: 4.036
|
| 2. |
Ayesha Naseer , Faisal Abdul rehman Osra , Asia Naz Awan,, Aqeel Imran , Abdul Hameed , Syed Adnan Ali Shah , Jamshed Iqbal and Zainul Amiruddin Zakaria (2022), "Exploring Novel Pyridine Carboxamide Derivatives As Urease Inhibitors: Synthesis, Molecular Docking, Kinetic Studies and ADME Profile", Pharmaceuticals , pp: 1288, Vol: 15, Issue: 10
(External URL)
|
| 3. |
Aqeel Imran, Muhammad Tariq Shehzad, Syed Jawad Ali Shah, Mark Laws, Taha al-Adhami, Khondaker Miraz Rahman, Imtiaz Ali Khan, Zahid Shafiq and Jamshed Iqbal. (2022), "Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway", ACS Omega , pp: 26425–26436, DOI: https://doi.org/10.1021/acsomega.2c02326, Impact Factor: 4.13
|
| 4. |
Aqeel Imran , MuhammadTariq Shehzad,Taha al Adhami, Khondaker Miraz Rahman Mark Laws, Rima al daharty, ZahidShafiq, Jamshed Iqbal (2022), "Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study", Scientific Reports , pp: 5734, Vol: 12, DOI: https://doi.org/10.1038/s41598-022-09658-z
|
| 5. |
Aqeel Imran MuhammadTariq Shehzad, Taha al Adhami, Khondaker Miraz Rahman, Dilawar Hussain, Zahid Shafiq, Jamshed Iqbal (2021), "Development of Coumarin-Thiosemicarbazone Hybrids as Aldose Reductase Inhibitors: Biological Assays, Molecular docking, Simulation studies and ADME Evaluation.", Bioorganic chemistry , pp: 105164, Vol: 115, DOI: https://doi.org/10.1016/j.bioorg.2021.105164, Impact Factor: 5.3
|